← Back
NeuroTrials.ai
Neurology Clinical Trial Database

EARLYDRAIN

Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage

Year of Publication: 2023

Authors: Stefan Wolf, Dorothee Mielke, Christoph Barner, ..., for the EARLYDRAIN Study Group

Journal: JAMA Neurology

Citation: JAMA Neurol. 2023;80(8):833-842

PDF: https://jamanetwork.com/journals/jamaneu...article/2806583


Clinical Question

Does prophylactic lumbar cerebrospinal fluid drainage improve clinical outcomes measured by the modified Rankin Scale score among patients with aneurysmal subarachnoid hemorrhage?

Bottom Line

In this pragmatic multicenter randomized trial of 287 patients with aneurysmal subarachnoid hemorrhage of all clinical grades, prophylactic lumbar drainage at 5 mL per hour for up to 8 days lessened the burden of secondary infarction and decreased the rate of unfavorable outcome at 6 months (32.6% vs 44.8%, RR 0.73, P=0.04). The number needed to treat was 8.3.

Major Points

  • Pragmatic, multicenter, open-label RCT with blinded endpoint evaluation at 19 centers in Germany, Switzerland, and Canada
  • Included 287 patients with aneurysmal SAH of all clinical grades (Hunt-Hess 1-5, WFNS 1-5)
  • Lumbar drainage started at median day 2 after SAH at 5 mL/hour for up to 8 days
  • Primary outcome (mRS 3-6 at 6 months) significantly reduced: 32.6% lumbar drain vs 44.8% standard care (RR 0.73, 95% CI 0.52-0.98, P=0.04)
  • Secondary infarctions at discharge significantly reduced: 28.5% vs 39.9% (RR 0.71, 95% CI 0.49-0.99, P=0.04)
  • No significant difference in vasospasm rates by clinical assessment, TCD, or angiography
  • Patients in lumbar drain group had significantly lower intracranial pressure
  • No difference in mortality at 6 months (13.2% vs 17.5%, NS)
  • Consistent benefit across prespecified subgroups
  • Per-protocol and as-treated sensitivity analyses confirmed findings
  • Lumbar drainage more efficient at removing blood from basal cisterns due to gravity effect

Design

Study Type: Pragmatic, multicenter, parallel-group, open-label randomized clinical trial with blinded end point evaluation

Randomization: 1

Blinding: Open-label for acute care providers, but blinded outcome assessment at 6 months by masked assessors; radiologists evaluating scans for secondary infarctions also blinded to treatment groups

Enrollment Period: January 31, 2011 to January 24, 2016

Follow-up Duration: 6 months after hemorrhage

Centers: 19

Countries: Germany, Switzerland, Canada

Sample Size: 287

Analysis: Intention-to-treat analysis as primary. Logistic regression for primary and secondary endpoints with transformation of odds ratios to risk ratios. Mixed models for repeated measurements. Per-protocol and as-treated sensitivity analyses performed. Statistical analysis with R version 4.1.0


Inclusion Criteria

  • Age ≥18 years
  • Acute aneurysmal subarachnoid hemorrhage diagnosed by computed tomography
  • Confirmation of intracranial aneurysm by CT angiography or digital subtraction angiography
  • Aneurysm treatment with clipping or coiling performed within 48 hours after subarachnoid hemorrhage
  • All clinical grades (Hunt-Hess 1-5, WFNS 1-5) were included

Exclusion Criteria

  • Contraindications for placement of lumbar drain
  • Absent or compressed basal cisterns on admission CT
  • Presence of therapeutic anticoagulation
  • Pregnancy
  • Participation in another interventional trial
  • Reduced life expectancy
  • Hemorrhage of other than aneurysmal origin

Baseline Characteristics

CharacteristicControlActive
n143144
Median age years56 (48-65)54 (48-63)
Female99 (69.2%)98 (68.1%)
Hunt-Hess grade 125 (17.5%)29 (20.1%)
Hunt-Hess grade 228 (19.6%)41 (28.5%)
Hunt-Hess grade 334 (23.8%)25 (17.4%)
Hunt-Hess grade 424 (16.8%)20 (13.9%)
Hunt-Hess grade 532 (22.4%)29 (20.1%)
WFNS grade 142 (29.4%)53 (36.8%)
WFNS grade 555 (38.5%)48 (33.3%)
Modified Fisher grade 479 (55.2%)85 (59%)
Intracerebral hemorrhage50 (35%)56 (38.9%)
Intraventricular hemorrhage85 (59.4%)90 (62.5%)
Anterior circulation aneurysm123 (86%)120 (83.3%)
Aneurysm coiling71 (treated patients)76 (treated patients)
External ventricular drain110 (76.9%)102 (70.8%)
Median daily lumbar drainage first 8 days108 (92-118) mL

Arms

FieldControlLumbar drain
InterventionStandard acute neurosurgical and neurocritical care for aneurysmal SAH including aneurysm treatment (clipping or coiling), nimodipine, and fluid management. External ventricular drainage at discretion of local team.Standard of care plus lumbar cerebrospinal fluid drain placed after aneurysm treatment. Lumbar CSF diversion started after postprocedural CT confirmed safety. Rate of 5 mL per hour recommended for first 8 days. Protocol-compliant treatment required at least 4 days, resulting in minimum 480 mL lumbar CSF drainage. ICP monitoring performed with zeroing of both ventricular and lumbar drains at level of external acoustic channel.
DurationAcute care phase with 6-month follow-upDrainage started within 72 hours of SAH (median day 2) and continued up to 8 days

Outcomes

OutcomeTypeControlInterventionHR / OR / RRP-value
Rate of unfavorable neurological outcome at 6 months after subarachnoid hemorrhage measured with modified Rankin Scale (mRS). mRS dichotomized to 0-2 (good outcome) or 3-6 (unfavorable outcome including death). Score obtained by investigator not involved in acute care and blinded to clinical course via telephone interview or personal visit.Primary64/143 (44.8%, 95% CI not specified)47/144 (32.6%, 95% CI not specified)12.12%P=0.04
Secondary infarctions at discharge - not present in postprocedural CT, diagnosed on last cerebral imaging before discharge (CT or MRI), radiologists blinded to treatment groupsSecondary57/143 (39.9%)41/144 (28.5%)RR 0.71 (95% CI 0.49-0.99)P=0.04
Mortality at 6 monthsSecondary25/143 (17.5%)19/144 (13.2%)RR 0.75 (95% CI 0.42-1.28)P=0.31
Clinically suspected vasospasmSecondary48/143 (33.6%)41/144 (28.5%)RR 0.85 (95% CI 0.58-1.18)P=0.35
Transcranial Doppler vasospasm (threshold 160 cm/s)Secondary31/125 (24.8%)36/134 (26.9%)RR 1.08 (95% CI 0.70-1.58)P=0.70
Angiographic vasospasmSecondary48/109 (44.0%)52/113 (46.0%)RR 1.04 (95% CI 0.76-1.34)P=0.77
Glasgow Outcome Scale-Extended grade 1-4 at 6 monthsSecondary54/143 (37.8%)38/144 (26.4%)RR 0.70 (95% CI 0.47-0.98)P=0.04
Barthel Index ≤80 at 6 months (among survivors)Secondary35/116 (30.2%)20/125 (16%)RR 0.53 (95% CI 0.30-0.86)P=0.01
Permanent ventriculoperitoneal shunt at 6 monthsSecondary42/143 (29.4%)41/144 (28.5%)RR 0.97 (95% CI 0.66-1.36)P=0.87
mRS score 3-6 at dischargeSecondary101/143 (70.6%)88/144 (61.1%)RR 0.87 (95% CI 0.69-1.02)P=0.09
Suspected infection of any causeAdverse52/143 (36.4%)56/144 (38.9%)RR 1.07 (95% CI 0.78-1.39)P=0.66
VP shunt during acute careAdverse34/143 (23.8%)34/144 (23.6%)RR 0.99 (95% CI 0.64-1.46)P=0.97
Increasing ICP gradient requiring drainage cessationAdverse1 patient
Local skin infection at drain entranceAdverse1 patient
Lumbar drain torn off requiring surgical removalAdverse1 patient
Mortality at dischargeAdverse22/143 (15.4%)15/144 (10.4%)RR 0.68 (95% CI 0.35-1.23)P=0.21

Subgroup Analysis

Effect of lumbar drains on primary outcome was consistent across all prespecified subgroups including age (≤55 vs >55 years), Hunt-Hess grade (1-2 vs 3-5), sex, WFNS grade (1-3 vs 4-5), modified Fisher grade (1-3 vs 4), presence/absence of intracerebral or intraventricular hemorrhage, aneurysm location (anterior vs posterior circulation), treatment modality (clipping vs coiling), presence/absence of external ventricular drain, and center size. No significant interaction detected.


Criticisms

  • Open-label design for acute care providers may introduce bias, though mitigated by blinded outcome assessment
  • Significant crossover: 35 of 144 (24%) lumbar drain patients did not receive protocol-compliant treatment; 2 of 143 (1.4%) standard care patients received high-volume lumbar drainage
  • Unable to secure sufficient funding for timely completion, prohibiting hiring of dedicated personnel
  • No data collected on preexisting hypertension and other premorbid prognostic factors
  • No detailed information on thickness of clots or amount of intraparenchymal/intraventricular blood on initial CT
  • Did not record medical complications during clinical course
  • Did not investigate additional application of clot thrombolysis or irrigation of subarachnoid space
  • Unable to evaluate benefit of higher drainage rates than 5 mL/hour
  • More than half of patients recruited from 2 centers, though investigators believe results are generalizable
  • Baseline imbalances: higher proportion of WFNS grades 1-2 in lumbar drain group; less intracerebral and intraventricular hemorrhages in standard care group
  • No adjustment for multiple testing on secondary endpoints - exploratory analyses only
  • Secondary infarction detection mainly by CT, which is less sensitive than MRI
  • Did not use current composite definition for delayed cerebral ischemia

Funding

Partially funded by the Center for Stroke Research (covering case report forms, ethics approval, randomization server, travel costs <€10,000). Additional costs covered by nonrestricted third-party funds to Charité University Medicine from Orsan Medical Systems (<€20,000). No case recruitment fee provided.

Based on: EARLYDRAIN (JAMA Neurology, 2023)

Authors: Stefan Wolf, Dorothee Mielke, Christoph Barner, ..., for the EARLYDRAIN Study Group

Citation: JAMA Neurol. 2023;80(8):833-842

Content summarized and formatted by NeuroTrials.ai.